U.S. markets closed
  • S&P Futures

    3,603.75
    +2.25 (+0.06%)
     
  • Dow Futures

    28,879.00
    +78.00 (+0.27%)
     
  • Nasdaq Futures

    11,000.00
    -35.50 (-0.32%)
     
  • Russell 2000 Futures

    1,673.10
    +3.30 (+0.20%)
     
  • Crude Oil

    81.90
    +2.41 (+3.03%)
     
  • Gold

    1,671.70
    -0.30 (-0.02%)
     
  • Silver

    19.10
    +0.07 (+0.35%)
     
  • EUR/USD

    0.9807
    -0.0013 (-0.13%)
     
  • 10-Yr Bond

    3.8040
    +0.0570 (+1.52%)
     
  • Vix

    31.62
    -0.22 (-0.69%)
     
  • GBP/USD

    1.1167
    +0.0044 (+0.39%)
     
  • USD/JPY

    144.7510
    +0.3080 (+0.21%)
     
  • BTC-USD

    19,199.33
    -120.40 (-0.62%)
     
  • CMC Crypto 200

    443.49
    +0.06 (+0.01%)
     
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • Nikkei 225

    25,937.21
    -484.89 (-1.84%)
     

Novavax COVID-19 vaccine authorized for U.S. teens

·1 min read
Novavax COVID-19 vaccine authorized for U.S. teens

The Food and Drug Administration authorized Novavax Inc.'s COVID-19 vaccine for use in U.S. teenagers on Friday. Novavax's recombinant protein-based vaccine uses different technology than the mRNA shots developed by Moderna Inc. and BioNTech SE , and received an emergency-use authorization by the FDA for adults in July. The vaccine still requires a policy recommendation for use by the Centers for Disease Control, which followed the FDA by about a week when authorizing the Novavax shot for adults